A unique model
IRIC, located in the heart of the Université de Montréal campus, operates according to a unique model in Canada that combines, under one roof, fundamental research activities, a university-level training program and a research maturation team. These generate discoveries that advance knowledge or that can quickly translate into new therapeutic solutions.
-
![]()
News Nearly $8,000 raised through the Beneva Montreal Marathon 2026!
The 2026 Montreal Beneva Marathon took place on the weekend of October 10. As a long-standing partner of the event, IRIC raised nearly $8,000 for cancer research thanks to more than 50 generous donors.
-
![]()
News Congratulations to the winners of the 2026 Concours science réflexion !
IRIC is pleased to announce the winners of the 2026 Concours science réflexion. This annual competition showcases the creativity and talent of the IRIC community.
-
![]()
News A $1 Million Investment for RejuvenRx, the First Recipient of Stem Cell Network’s New Program
RejuvenRx, a biotechnology company co-founded by Anne Marinier and Guy Sauvageau, principal investigators at IRIC at the Université de Montréal, has been awarded a $1 million investment by Stem Cell Network (SCN).
-
![]()
Event Scientific Conferences - Fall 2026
September 14—December 13, 2026
IRIC presents the 41st edition of its scientific lecture series—Fall 2026.
-
![]()
News IRIC is heading out to meet the next generation again this fall!
As part of its IRIC on the Road student recruitment tour, the Institute’s Academic Affairs team will participate this fall in several graduate school fairs organized by Canadian universities.
These fairs give students the opportunity to meet with our representatives to learn more about the academic programs and internships offered, admission requirements, and scholarship opportunities.
-
![]()
News Science at the heart of Summer Interns’ Scientific Day at IRIC!
The 8th IRIC Summer Summer Interns’ Scientific Day once again showcased the talent, creativity, and dedication of our young scientists. The event was organized by the IRIC Office of Academic Affairs in collaboration with summer interns.
-
![]()
News Nearly $2 million in funding for the acquisition of state-of-the-art equipment at IRIC
The Canada Foundation for Innovation (CFI) recently announced the results of its John R. Evans Leaders Fund competition. This program enables universities to attract and retain world-class researchers in Canada by providing them with state-of-the-art infrastructure. The CFI’s funding is supplemented by the Government of Quebec and other partners. Two IRIC projects have been awarded grants through this program.
Upcoming events
-
Upcoming 27—20 May, 2027 Audace Gala - IRIC Fundraising Event
Since 2014, IRIC has organized the Audace Gala fundraising event, which helps fund promising discoveries in the fight against cancer each year.
The Audace Gala is much more than just an evening event: it is a time for sharing, solidarity, and hope. Let’s unite our generous hearts to support therapeutic advances through cancer research.
Latest publications
See all publications-
October 2, 2026 EZH2 Inhibition Induces a Metabolic Stress Response Sensitizing Triple-Negative Breast Cancer to Glutaminase Targeting.
Porras L, Carrière M, Gironne AS, Philippeau H, Alzial G, Quadri E, Cormery J, Alaessa Y, Monast A, Gorse F, St-Arnaud M, De Sa Tavares Russo M, Mader S, Avizonis DZ, Lemieux S, Park M, Deblois G
Cancer Res 2026-10-02 ; -
September 11, 2026 Mice with the mono-allelic p.R37H Dhdds variant show aberrant glycosylation and interneuron deficits.
Da Silva A, Fallah MS, Tene Tadoum SB, Fazeli M, Muffels IJJ, Wang S, Grenier F, Budhraja R, Sturiale L, Messina A, Giladi M, Taherzadeh M, Bonneil E, Khan S, Vruchte DT, Yamanaka Y, Di Cristo G, Hamdan FF, Platt FM, Tomatsu S, Haitin Y, Kozicz T, Thibault P, Garozzo D, Pandey A, Morava E, Rossignol E, Pshezhetsky AV
Brain 2026-09-11 ; -
August 31, 2026 Lysyl oxidase inhibition disrupts mitochondrial homeostasis to create vulnerability to ferroptosis in TNBC.
Saatci O, Ulukan B, Cetin M, Kuasne H, Martinez C, Percin E, Oleinik N, Savoca MT, Nehme A, Hernández-Corchado A, Zavacky E, Sreenivas K, Rezaeian AH, Bethard JR, Anoma JS, Sahin OS, Aguilar-Mahecha A, Buchanan M, Aras M, DeBlois G, Basik M, Hill EG, Ball LE, Rao CN, McInnes C, Riazalhosseini Y, Najafabadi HS, Lemasters JJ, Ogretmen B, Park M, Sahin O
Cell Rep Med 2026-08-31 ;7( 9 ):103015 - See all publications